Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
06/2012
06/21/2012US20120157522 B. Anthracis Prevention and Treatment: Mutant B. Anthracis Lacking Luxs Activity and Furanone Inhibition of Growth, AI-2 Quorum Sensing, and Toxin Production
06/21/2012US20120157514 Oligomeric compounds and compositions for use in modulation of small non-coding rnas
06/21/2012US20120157511 5' phosphate mimics
06/21/2012US20120157509 GALACTOSE CLUSTER-PHARMACOKINETIC MODULATOR TARGETING MOIETY FOR siRNA
06/21/2012US20120157344 Gene expression signature for classification of kidney tumors
06/21/2012US20120157343 System and Methods to Quantify and Amplify Both Signaling and Probes for cDNA Chips and Gene Expression Microarrays
06/21/2012US20120157333 Oligonucleotides useful for detecting and analyzing nucleic acids of interest
06/21/2012US20120157329 Method and Device for the in Vitro Analysis for MRNA of Genes Involved in Haematological Neoplasias
06/21/2012US20120157327 Labelling Strategies for the Sensitive Detection of Analytes
06/21/2012US20120157326 Stem accelerated isothermal nucleic acid amplification technology
06/21/2012US20120157324 Methylation biomarkers and methods of use
06/21/2012US20120156754 Variant cbh2 cellulases and related polynucleotides
06/21/2012US20120156752 Production of nucleic acid
06/21/2012US20120156751 Preparation and isolation of 5' capped mrna
06/21/2012US20120156731 Improved Methods for Rapid Gene Synthesis
06/21/2012US20120156729 Selective terminal tagging of nucleic acids
06/21/2012US20120156704 In vitro method for detecting gp91phox as a marker of oxidative stress
06/21/2012US20120156694 Proteins used for the diagnosis of lyme borreliosis
06/21/2012US20120156683 One-step method of elution of dna from blood samples
06/21/2012US20120156681 Composition for diagnosis of liver metastasis of colorectal cancer and the use thereof
06/21/2012US20120156676 Single nucleotide polymorphisms in brca1 and cancer risk
06/21/2012US20120156671 Labelled nucleotides
06/21/2012US20120156329 Expression Of Granular Starch Hydrolyzing Enzymes In Trichoderma And Process For Producing Glucose From Granular Starch Substrates
06/21/2012US20120156310 Method for prediction of therapeutic effect of chemotherapy employing expression level of dihydropyrimidine dehydrogenase gene as measure
06/21/2012US20120156242 An Antigenic Peptide Derived From Influenza Virus And A Method For Selecting Anti-Influenza Virus Antibody
06/21/2012US20120156231 Foxm1 peptides and vaccines containing the same
06/21/2012US20120156226 Marker Differentially Expressed in Cancer Stem Cells and Methods of Using Same
06/21/2012US20120156220 Methods and compositions for inhibiting cd32b expressing cells
06/21/2012US20120156215 Phage-GnRH Constructs, Their Mimics, Antigenic Compositions, and Sequences for Immunocontraception of Animals and Other Applications
06/21/2012US20120156213 Method for treating th17 inflammatory disease through inhibition of vascular endothelial growth factor receptors and pharmaceutical composition therefor
06/21/2012US20120156194 Diagnosis and treatments relating to th2 inhibition
06/21/2012US20120156180 Compositions and methods for the treatment of krabbe and other neurodegenerative diseases
06/21/2012US20120156167 Enhancin gene bel1 from bacillus thuringiensis and its use in biological insecticide
06/21/2012US20120156162 Perhydrolase variant providing improved specific activity
06/21/2012US20120156161 Perhydrolase variant providing improved specific activity
06/21/2012US20120156160 Perhydrolase variant providing improved specific activity
06/21/2012US20120156140 Fluorescent compounds
06/21/2012DE102011006610B3 Aptamere, die spezifisch sind für Immunoglobulin bindende Zellwandproteine Aptamers that are specific for immunoglobulin binding cell wall proteins
06/21/2012CA2821101A1 Soybean event syht0h2 and compositions and methods for detection thereof
06/21/2012CA2816155A1 Galactose cluster-pharmacokinetic modulator targeting moiety for sirna
06/20/2012EP2465930A2 Amylase variants
06/20/2012EP2465520A2 Epitope sequences
06/20/2012EP2465511A2 Methods and compositions for generating an immune response by inducing CD40 and pattern recognition receptors and adaptors thereof
06/20/2012EP2465510A2 Methods and compositions for generating an immune response by inducing CD40 and pattern recognition receptors and adaptors thereof
06/20/2012EP2464748A1 Detection and analysis of methylation in nucleic acid sequences
06/20/2012CN102510903A Improvements in mass spectrum-based identification and quantitation of proteins and peptides
06/20/2012CN101735297B Method for quickly extracting low molecular weight RNA of plant
06/20/2012CN101410406B 6-modified bicyclic nucleic acid analogs
06/20/2012CN101128475B Delta15 desaturases suitable for altering levels of polyunsaturated fatty acids in oilseed plants and oleaginous yeast
06/19/2012US8202985 Monomer compositions for the synthesis of polynucleotides, methods of synthesis, and methods of deprotection
06/19/2012US8202983 Thiocarbon-protecting groups for RNA synthesis
06/19/2012US8202982 Methods of obtaining active antisense compounds
06/19/2012US8202981 Compositions and their uses directed to PTPRU
06/19/2012US8202980 Antisense oligonucleotide for use in prevention and treatment of viral and tumor disorders; gene expression inhibition; RNA interference
06/19/2012US8202979 siNA molecule comprising a double-stranded structure that down-regulates expression of a target nucleic acid, wherein said siNA molecule does not require a 2'-hydroxyl group containing ribonucleotide; treating viral diseases such as SARS (severe acute respiratory syndrome virus), herpes, hepatitis, HIV
06/19/2012US8202978 Compositions for detecting group A streptococci
06/19/2012US8202976 Nucleic acid molecules that encode human anti-IFN-gamma neutralizing antibodies as selective IFN-gamma pathway inhibitors
06/19/2012US8202974 Synthetic RNA-based agonists of TLR7
06/19/2012US8202973 Method for the production of vitamin K-dependent proteins
06/19/2012US8202972 Isothermal DNA amplification
06/19/2012US8202968 Predicting lung cancer survival using gene expression
06/19/2012US8202851 Antisense oligonucleotides for treating allergy and neoplastic cell proliferation
06/19/2012US8202850 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
06/19/2012US8202849 Methods and compositions for the inhibition of Stat5 in prostate cancer cells
06/19/2012US8202845 Means and methods for the specific modulation of target genes in the CNS and the eye and methods for their identification
06/19/2012US8202831 Detergent composition comprising a variant of a family 44 xyloglucanase
06/19/2012US8202823 Structural nucleic acid guided chemical synthesis
06/19/2012US8202727 Using vector transformation and propagation to replicate preferential nucleotide sequences
06/19/2012US8202718 Ecdysone receptor-based inducible gene expression system
06/19/2012US8202716 Thermophilic and thermoacidophilic biopolymer-degrading genes and enzymes from alicyclobacillus acidocaldarius and related organisms, methods
06/19/2012US8202715 Cloning, expression and use of acid lysophospholipases
06/19/2012US8202694 Composition comprising an oligonucleotide mixture for improved detection of human papillomavirus genotypes
06/19/2012US8202691 Uniform fragmentation of DNA using binding proteins
06/19/2012US8202544 High capacity non-viral vectors
06/19/2012US8202517 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
06/19/2012US8202427 Porous ferro-or ferrimagnetic glass particles for isolating molecules
06/19/2012CA2656185C Method for treating diabetic vascular complications
06/19/2012CA2496821C Selection and isolation of living cells using rna-binding probes
06/19/2012CA2457754C Terminal-phosphate-labeled nucleotides and methods of use
06/19/2012CA2442438C Oligonucleotide-immobilized substrate for detecting methylation
06/19/2012CA2398432C Modulation of oligonucleotide cpg-mediated immune stimulation by positional modification of nucleosides
06/19/2012CA2397606C Method for synthesising and immobilizing nucleic acids on a silanized solid support
06/19/2012CA2241726C Genes and gene products related to werner's syndrome
06/14/2012WO2012079000A1 Use of chimeric antigen receptor-modified t cells to treat cancer
06/14/2012WO2012078773A2 Optimized probes and primers and methods of using same for the detection, screening, isolation and sequencing of mrsa, mssa, staphylococcus markers, and the antibiotic resistance gene mec a
06/14/2012WO2012078637A2 Composition and method for oligonucleotide delivery
06/14/2012WO2012078536A2 Double stranded oligonucleotide compounds comprising positional modifications
06/14/2012WO2012078416A2 Monophosphate prodrugs of dapd and analogs thereof
06/14/2012WO2012077800A1 Novel nucleoside analog and utilization thereof
06/14/2012WO2012048013A3 Phosphorodiamidate derivatives of guanosine nucleoside compounds for treatment of viral injections
06/14/2012WO2012007945A3 Isolated polynucleotides and methods and plants using same for regulating plant acidity
06/14/2012WO2012006243A3 Methods and compositions for the specific inhibition of beta-catenin by double-stranded rna
06/14/2012WO2011097092A4 Solid-supported ether disulfides
06/14/2012WO2008014521A8 Improved vaccines and methods for using the same
06/14/2012US20120151632 Phospholipases and methods of using same
06/14/2012US20120151631 Insect pest control method
06/14/2012US20120151621 Genes for microsomal delta-12 fatty acid desaturases and hydroxylases from plants
06/14/2012US20120149893 Modulation of eif4e-bp2
06/14/2012US20120149891 Brassica indehiscent1 sequences
06/14/2012US20120149890 Polynucleotides Encoding Thymidine Kinase Mutants
1 ... 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 ... 899